Literature DB >> 20682918

A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program.

John F Scoggins, Scott D Ramsey.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20682918      PMCID： PMC2935476          DOI： 10.1093/jnci/djq291

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  107 in total

1.  The importance of doing trials right while doing the right trials.

Authors:  David M Dilts; Steven K Cheng
Journal:  Clin Cancer Res       Date:  2011-11-09       Impact factor: 12.531

2.  Cooperative Group Cancer Clinical Trials: An NCIC Clinical Trials Group Perspective.

Authors:  Ralph M Meyer; Heather A Stanton; Wendy R Parulekar; Fred Saad
Journal:  Can Urol Assoc J       Date:  2011-12       Impact factor: 1.862

3.  Implications of the oropharyngeal cancer epidemic.

Authors:  Edmund A Mroz; Arlene A Forastiere; James W Rocco
Journal:  J Clin Oncol       Date:  2011-10-03       Impact factor: 44.544

4.  Issues surrounding biospecimen collection and use in clinical trials.

Authors:  Allison R Baer; Mary Lou Smith; Deborah Collyar; Jeffrey Peppercorn
Journal:  J Oncol Pract       Date:  2010-07       Impact factor: 3.840

5.  A strategy to advance the evidence base in palliative medicine: formation of a palliative care research cooperative group.

Authors:  Amy P Abernethy; Noreen M Aziz; Ethan Basch; Janet Bull; Charles S Cleeland; David C Currow; Diane Fairclough; Laura Hanson; Joshua Hauser; Danielle Ko; Linda Lloyd; R Sean Morrison; Shirley Otis-Green; Steve Pantilat; Russell K Portenoy; Christine Ritchie; Graeme Rocker; Jane L Wheeler; S Yousuf Zafar; Jean S Kutner
Journal:  J Palliat Med       Date:  2010-11-24       Impact factor: 2.947

6.  Bayesian adaptive randomized trial design for patients with recurrent glioblastoma.

Authors:  Lorenzo Trippa; Eudocia Q Lee; Patrick Y Wen; Tracy T Batchelor; Timothy Cloughesy; Giovanni Parmigiani; Brian M Alexander
Journal:  J Clin Oncol       Date:  2012-05-29       Impact factor: 44.544

7.  Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act.

Authors:  Kenneth L Kehl; Cheryl P Fullmer; Siqing Fu; Goldy C George; Kenneth R Hess; Filip Janku; Daniel D Karp; Shumei Kato; Cynthia K Kizer; Razelle Kurzrock; Aung Naing; Shubham Pant; Sarina A Piha-Paul; Vivek Subbiah; Apostolia M Tsimberidou; David S Hong
Journal:  Clin Cancer Res       Date:  2017-07-20       Impact factor: 12.531

8.  Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.

Authors:  Aisha T Langford; Ken Resnicow; Eileen P Dimond; Andrea M Denicoff; Diane St Germain; Worta McCaskill-Stevens; Rebecca A Enos; Angela Carrigan; Kathy Wilkinson; Ronald S Go
Journal:  Cancer       Date:  2013-12-10       Impact factor: 6.860

9.  From Famine to Feast: Developing Early-Phase Combination Immunotherapy Trials Wisely.

Authors:  Daphne Day; Arta M Monjazeb; Elad Sharon; S Percy Ivy; Eric H Rubin; Gary L Rosner; Marcus O Butler
Journal:  Clin Cancer Res       Date:  2017-09-01       Impact factor: 12.531

10.  Survival of women diagnosed with breast cancer and who have survived a previous cancer.

Authors:  Sandi L Pruitt; Hong Zhu; Daniel F Heitjan; Asal Rahimi; Bhumika Maddineni; Anna Tavakkoli; Ethan A Halm; David E Gerber; Danyi Xiong; Caitlin C Murphy
Journal:  Breast Cancer Res Treat       Date:  2021-02-23       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.